PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Aug-2024 NHI Announces Second Quarter 2024 Results AccessWire
06-Aug-2024 Evotec provides guidance update Evotec SE
06-Aug-2024 Evotec SE provides guidance update Evotec SE
06-Aug-2024 Integrated DNA Technologies Bolsters Synthetic Biology Portfolio with Launch of Rapid Genes and Significant Upgrades to Gene Synthesis Offerings Integrated DNA Technologies
06-Aug-2024 Ultrasound Probe Disinfection Market Set to Reach USD 1.5 Billion by 2032 Global Market Insights, Inc.
06-Aug-2024 Adoption of ICH E6 (R3) is Coming Pharma Lessons
06-Aug-2024 Medical Affairs Summit marcusevans
06-Aug-2024 Vibrant Wellness Improves Turnaround Times for Key Lab Tests AccessWire
06-Aug-2024 VivaWell and Keyzell Holding Announce Strategic Global Cooperation to Develop Innovative AI Health Solutions AccessWire
06-Aug-2024 Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share AccessWire
06-Aug-2024 OS Therapies Announces Osteosarcoma Scientific and Medical Advisory Board AccessWire
06-Aug-2024 Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology AccessWire
06-Aug-2024 Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations AccessWire
06-Aug-2024 Sunshine Biopharma Announces Reverse Stock Split AccessWire
06-Aug-2024 Ainos Concludes Growth Financing From Lind Partners AccessWire
06-Aug-2024 Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation Clinion Inc
06-Aug-2024 Acreage Commences Non-Medical Cannabis Sales in Ohio AccessWire
06-Aug-2024 Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update AccessWire
06-Aug-2024 Formycon AG increases its outlook for the 2024 fiscal year Formycon AG
06-Aug-2024 QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform QUANTRO Therapeutics GmbH